Private Placement

With enrollment complete for three major trials, MediciNova braces for a transformative year with crucial data expected for its ALS and metabolic disease candidates.

Facing cautious investors, Silicom bets its future on next-gen tech like PQC and Edge. Can its bold growth plans overcome recent financial turbulence?

From e-commerce to tech licensor, Linkage Global unveils smart headphones with AI translation and cultural heritage designs at CES 2026.

Menlo Ventures promotes General Counsel Deborah Carrillo to Partner, a move reflecting a crucial industry shift where legal expertise is now a core strategic asset.

With a new $195M credit facility led by JPMorgan Chase, DailyPay strengthens its position in the evolving world of employee financial wellness.

BridGene Biosciences adds Nobel winner Dr. Bruce Beutler to its board, gaining immense credibility for its mission to create drugs for intractable diseases.

With stunning clinical data for its miv-cel therapy, Kyverna is set to outline a new era for autoimmune treatment at the J.P. Morgan conference.

With a key presentation looming, Star Therapeutics aims to showcase its universal hemostatic therapy, VGA039, for von Willebrand disease.

A landmark $1.2M order for its advanced LineaDNA validates the firm's biotech arm, but can scientific success balance its new, volatile crypto strategy?

South Korea's Curogen secures major national funding and targets global partners at the JP Morgan conference, advancing novel therapies for IBD and HS.

With a key drug decision looming and a refocused strategy, Rocket Pharmaceuticals faces a critical audience at the J.P. Morgan Healthcare Conference.

With key trials in brain and prostate cancer, Curasight heads to a top investor conference to showcase its dual-action theranostic technology.

Benfen Inc. launches a self-custody card letting users earn DeFi yield while keeping funds spendable, aiming to solve crypto's liquidity puzzle.

International Petroleum Corp. is ahead of schedule and on budget at its massive Blackrod oil sands project, signaling a major win for Canadian energy.

As Bank of Marin prepares its Q4 earnings call, investors are watching how its 2025 strategic shifts will fare against Northern California's mixed economy.

StickIt Technologies bets on a complex share consolidation and capital raise to survive, but are the terms a red flag for its investors and future?

Genelux appoints Dr. Jason Litten as CMO, a strategic move to steer its promising oncolytic virus, Olvi-Vec, through crucial late-stage cancer trials.

Intelligent Bio Solutions raised crucial capital for its fingerprint drug test, but the deal's structure sent shares tumbling amid shareholder dilution fears.

The junior explorer has raised crucial capital to advance its drilling programs in Quebec's prolific gold belt, signaling strong investor confidence.

Cannabix Technologies lands its first international order for its smart breathalyzer in Australia, a move that validates its tech and reshapes its finances.